Is Genscript Biotech stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Genscript Biotech pays dividends. Last time was Wednesday 21st of June 2017 where the investors holding the stock on Monday 5th of June 2017 were paid $0.00153998 per share. Over the last 1 times between 2017 and 2017, Genscript Biotech has paid $0.00153998 with an average of $0 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Genscript Biotech 10 years ago, but if you had invested on Friday 22nd of November 2019 when the price was $2.50, you would have made a loss of $-1.120 per share or -44.80%
No, the average daily trading liquidity for Genscript Biotech is $500 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.
Genscript Biotech has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.
We have calculated the inflation risk for Genscript Biotech to be high [0.75 of 1]
US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.